Literature DB >> 19545229

Electroporation advances in large animals.

Scott D Reed1, Shulin Li.   

Abstract

In vivo electroporation-mediated gene therapy in large animals is gaining ground as one of the most important means for non-viral gene therapy. This review focuses on the novel aspects of reversible electroporation as applied to large animals, improvement of electroporation delivery technique, and development of electroporation-based vaccines. In regard to large animals, we have summarized the initial use of electroporation-mediated antineoplastic gene therapy in humans, vaccination in monkeys, reversing and preventing cachexia in dogs, and increases growth rate and piglet survival in pigs. Novel techniques incorporating electroporation, including ex vivo manipulations, electron avalanche transfection, and electrosonoporation illustrate evolving modifications. Specific alterations of electroporation parameters and DNA formulations along with ideas of enhancing gene transfection efficiency are provided in addition to a discussion of some of the current limitations of electroporation-mediated gene therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545229      PMCID: PMC3046214          DOI: 10.2174/156652309788921062

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  126 in total

1.  Irreversible electroporation: a new ablation modality--clinical implications.

Authors:  Boris Rubinsky; Gary Onik; Paul Mikus
Journal:  Technol Cancer Res Treat       Date:  2007-02

Review 2.  Gene transfer using nonviral delivery systems.

Authors:  Masanobu Miyazaki; Yoko Obata; Katsushige Abe; Akira Furusu; Takehiko Koji; Yasuhiko Tabata; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2006 Nov-Dec       Impact factor: 1.756

Review 3.  Electrotransfer as a non viral method of gene delivery.

Authors:  Cyril Favard; David S Dean; Marie-Pierre Rols
Journal:  Curr Gene Ther       Date:  2007-02       Impact factor: 4.391

4.  Variability of naked DNA expression after direct local injection: the influence of the injection speed.

Authors:  F M André; C Cournil-Henrionnet; D Vernerey; P Opolon; L M Mir
Journal:  Gene Ther       Date:  2006-07-27       Impact factor: 5.250

5.  Production of cattle lacking prion protein.

Authors:  Jürgen A Richt; Poothappillai Kasinathan; Amir N Hamir; Joaquin Castilla; Thillai Sathiyaseelan; Francisco Vargas; Janaki Sathiyaseelan; Hua Wu; Hiroaki Matsushita; Julie Koster; Shinichiro Kato; Isao Ishida; Claudio Soto; James M Robl; Yoshimi Kuroiwa
Journal:  Nat Biotechnol       Date:  2006-12-31       Impact factor: 54.908

6.  Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy.

Authors:  Yuji Ueda; Tsuyoshi Itoh; Nobuaki Fuji; Sachio Harada; Hiroshi Fujiki; Keiji Shimizu; Atsushi Shiozaki; Arihiro Iwamoto; Takeshi Shimizu; Osam Mazda; Takafumi Kimura; Yoshiaki Sonoda; Masafumi Taniwaki; Hisakazu Yamagishi
Journal:  Cancer Immunol Immunother       Date:  2006-07-08       Impact factor: 6.968

7.  Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.

Authors:  Hong Yu; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Vaccine       Date:  2006-12-05       Impact factor: 3.641

8.  Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.

Authors:  Xizhong Zhang; Maziar Divangahi; Patricia Ngai; Michael Santosuosso; James Millar; Anna Zganiacz; Jun Wang; Jonathan Bramson; Zhou Xing
Journal:  Vaccine       Date:  2006-10-10       Impact factor: 3.641

9.  A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis.

Authors:  Shin Onodera; Shigeki Ohshima; Harukazu Tohyama; Kazunori Yasuda; Jun Nishihira; Yoichiro Iwakura; Ikkei Matsuda; Akio Minami; Yoshikazu Koyama
Journal:  Arthritis Rheum       Date:  2007-02

10.  Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APC.

Authors:  Shigemi Sasawatari; Toshimasa Tadaki; Manami Isogai; Masashi Takahara; Mie Nieda; Kazuhiro Kakimi
Journal:  Immunol Cell Biol       Date:  2006-07-20       Impact factor: 5.126

View more
  9 in total

1.  Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes.

Authors:  Qiu Zhong; Dakshina Murthy Devanga Chinta; Sarala Pamujula; Haifan Wang; Xin Yao; Tarun K Mandal; Ronald B Luftig
Journal:  J Nanobiotechnology       Date:  2010-02-24       Impact factor: 10.435

2.  Pre-clinical toxicity assessment of tumor-targeted interleukin-12 low-intensity electrogenetherapy.

Authors:  S D Reed; S Li
Journal:  Cancer Gene Ther       Date:  2011-01-14       Impact factor: 5.987

3.  A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.

Authors:  Lesley C Dupuy; Michelle J Richards; Barry Ellefsen; Lillian Chau; Alain Luxembourg; Drew Hannaman; Brian D Livingston; Connie S Schmaljohn
Journal:  Clin Vaccine Immunol       Date:  2011-03-30

4.  Electrotransfection and lipofection show comparable efficiency for in vitro gene delivery of primary human myoblasts.

Authors:  Tomaz Mars; Marusa Strazisar; Katarina Mis; Nejc Kotnik; Katarina Pegan; Jasna Lojk; Zoran Grubic; Mojca Pavlin
Journal:  J Membr Biol       Date:  2014-12-23       Impact factor: 1.843

5.  Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.

Authors:  S D Reed; A Fulmer; J Buckholz; B Zhang; J Cutrera; K Shiomitsu; S Li
Journal:  Cancer Gene Ther       Date:  2010-02-12       Impact factor: 5.987

6.  Numerical optimization of gene electrotransfer into muscle tissue.

Authors:  Anze Zupanic; Selma Corovic; Damijan Miklavcic; Mojca Pavlin
Journal:  Biomed Eng Online       Date:  2010-11-04       Impact factor: 2.819

Review 7.  Plasmid IL-12 electroporation in melanoma.

Authors:  Edward Cha; Adil Daud
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

Review 8.  Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle.

Authors:  Douglas J Blackiston; Kelly A McLaughlin; Michael Levin
Journal:  Cell Cycle       Date:  2009-11-24       Impact factor: 4.534

Review 9.  Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Authors:  Congcong Zhang; Rina M Ötjengerdes; Julian Roewe; Rebeca Mejias; Andrea L J Marschall
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.